High interstitial fluid pressure is associated with tumor-line specific vascular abnormalities in human melanoma xenografts

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Simonsen, Trude G ^a   Gaustad, Jon Vidar ^a   Leinaas, Marit N ^a   Rofstad, Einar K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD VESSEL PARAMETERS; CAPILLARY; FEMALE; GROWTH RATE; MELANOMA; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; TISSUE PRESSURE; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; VASCULAR DENSITY; VASCULAR DISEASE; VASCULAR RESISTANCE; VENULE;

ANIMALS; ARTERIOLES; BLOOD VESSELS; CELL LINE, TUMOR; EXTRACELLULAR FLUID; FEMALE; GREEN FLUORESCENT PROTEINS; HUMANS; MELANOMA; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; PRESSURE; REGIONAL BLOOD FLOW; SKIN NEOPLASMS; TIME FACTORS; VENULES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 84863100449     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040006     Document Type: Article

References (48)

1. Lunt SJ, Fyles A, Hill RP, Milosevic M, (2008) Interstitial fluid pressure in tumors: therapeutic barrier and biomarker of angiogenesis. Future Oncol 4: 793-802.
2. Less JR, Posner MC, Boucher Y, Borochovitz D, Wolmark N, et al. (1992) Interstitial hypertension in human breast and colorectal tumors. Cancer Res 52: 6371-6374.
3. Boucher Y, Kirkwood JM, Opacic D, Desantis M, Jain RK, (1991) Interstitial hypertension in superficial metastatic melanomas in humans. Cancer Res 51: 6691-6694.
4. Milosevic MF, Fyles AW, Wong R, Pintilie M, Kavanagh MC, et al. (1998) Interstitial fluid pressure in cervical carcinoma: within tumor heterogeneity, and relation to oxygen tension. Cancer 82: 2418-2426.
5. Curti BD, Urba WJ, Alvord WG, Janik JE, Smith JW, et al. (1993) Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment. Cancer Res 53: 2204-2207.
6. Heldin CH, Rubin K, Pietras K, Ostman A, (2004) High interstitial fluid pressure- an obstacle in cancer therapy. Nat Rev Cancer 4: 806-813.
7. Baxter LT, Jain RK, (1989) Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. Microvasc Res 37: 77-104.
8. Salnikov AV, Iversen VV, Koisti M, Sundberg C, Johansson L, et al. (2003) Lowering of tumor interstitial fluid pressure specifically augments efficacy of chemotherapy. FASEB J 17: 1756-1758.
9. Milosevic M, Fyles A, Hedley D, Pintilie M, Levin W, et al. (2001) Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. Cancer Res 61: 6400-6405.
10. Yeo SG, Kim JS, Cho MJ, Kim KH, Kim JS, (2009) Interstitial fluid pressure as a prognostic factor in cervical cancer following radiation therapy. Clin Cancer Res 15: 6201-6207.
11. Rofstad EK, Gaustad JV, Brurberg KG, Mathiesen B, Galappathi K, et al. (2009) Radiocurability is associated with interstitial fluid pressure in human tumor xenografts. Neoplasia 11: 1243-1251.
12. Rofstad EK, Ruud EB, Mathiesen B, Galappathi K, (2010) Associations between radiocurability and interstitial fluid pressure in human tumor xenografts without hypoxic tissue. Clin Cancer Res 16: 936-945.
13. Rofstad EK, Tunheim SH, Mathiesen B, Graff BA, Halsør EF, et al. (2002) Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts. Cancer Res 62: 661-664.
14. Jain RK, (1987) Transport of molecules across tumor vasculature. Cancer Metastasis Rev 6: 559-593.
15. Jain RK, (1988) Determinants of tumor blood flow: a review. Cancer Res 48: 2641-2658.
16. Vaupel P, Kallinowski F, Okunieff P, (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449-6465.
17. Less JR, Posner MC, Skalak TC, Wolmark N, Jain RK, (1997) Geometric resistance and microvascular network architecture of human colorectal carcinoma. Microcirculation 4: 25-33.
18. Boucher Y, Jain RK, (1992) Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 52: 5110-5114.
19. Padera TP, Kadambi A, Di Tomaso E, Carreira CM, Brown EB, et al. (2002) Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296: 1883-1886.
20. Boucher Y, Baxter LT, Jain RK, (1990) Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res 50: 4478-4484.
21. Boucher Y, Leunig M, Jain RK, (1996) Tumor angiogenesis and interstitial hypertension. Cancer Res 56: 4264-4266.
22. Carmeliet P, Jain RK, (2000) Angiogenesis in cancer and other diseases. Nature 407: 249-257.
23. Folkman J, (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31.
24. Netti PA, Baxter LT, Boucher Y, Skalak R, Jain RK, (1995) Time-dependent behavior of interstitial fluid pressure in solid tumors: implications for drug delivery. Cancer Res 55: 5451-5458.
25. Al-Olama M, Wallgren A, Andersson B, Gatzinsky K, Hultborn R, et al. (2011) The peptide AF-16 decreases high interstitial fluid pressure in solid tumors. Acta Oncol 50: 1098-1104.
26. Sen A, Capitano ML, Spernyak JA, Schueckler JT, Thomas S, et al. (2011) Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia and enhances efficacy of radiotherapy in murine tumor models. Cancer Res 71: 3872-3880.
27. Jain RK, (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307: 58-62.
28. Klosowska-Wardega A, Hasumi Y, Burmakin M, Ahgren A, Stuhr L, et al. (2009) Combined anti-angiogenic therapy targeting PDGF and VEGF receptors lowers the interstitial fluid pressure in a murine experimental carcinoma. PLoS One 4: e8149.
29. Tailor TD, Hanna G, Yarmolenko PS, Dreher MR, Betof AS, et al. (2010) Effect of pazopanib on tumor microenvironment and liposome delivery. Mol Cancer Ther 9: 1798-1808.
30. Willett CG, Boucher Y, Di Tomaso E, Duda DG, Munn LL, et al. (2004) Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10: 145-147.
31. Rofstad EK, (1994) Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern. Br J Cancer 70: 804-812.
32. Rofstad EK, Wahl A, Davies CL, Brustad T, (1986) Growth characteristics of human melanoma multicellular spheroids in liquid-overlay culture: comparisons with the parent tumour xenografts. Cell Tissue Kinet 19: 205-216.
33. Gaustad JV, Brurberg KG, Simonsen TG, Mollatt CS, Rofstad EK, (2008) Tumor vascularity assessed by magnetic resonance imaging and intravital microscopy imaging. Neoplasia 10: 354-362.
34. Tozer GM, Ameer-Beg SM, Baker J, Barber PR, Hill SA, et al. (2005) Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopy. Adv Drug Deliv Rev 57: 135-152.
35. Øye KS, Gulati G, Graff BA, Gaustad JV, Brurberg KG, et al. (2008) A novel method for mapping the heterogeneity in blood supply to normal and malignant tissues in the mouse dorsal window chamber. Microvasc Res 75: 179-187.
36. Gaustad JV, Simonsen TG, Brurberg KG, Huuse EM, Rofstad EK, (2009) Blood supply in melanoma xenografts is governed by the morphology of the supplying arteries. Neoplasia 11: 277-285.
37. Ozerdem U, Hargens AR, (2005) A simple method for measuring interstitial fluid pressure in cancer tissues. Microvasc Res 70: 116-120.
38. Rofstad EK, Måseide K, (1999) Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours. Int J Radiat Biol 75: 1377-1393.
39. Gulliksrud K, Brurberg KG, Rofstad EK, (2009) Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure. Radiother Oncol 91: 107-113.
40. Tufto I, Lyng H, Rofstad EK, (1998) Vascular density in human melanoma xenografts: relationship to angiogenesis, perfusion and necrosis. Cancer Lett 123: 159-165.
41. Vajkoczy P, Ullrich A, Menger MD, (2000) Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation. Neoplasia 2: 53-61.
42. Sevick EM, Jain RK, (1991) Measurement of capillary filtration coefficient in a solid tumor. Cancer Res 51: 1352-1355.
43. Brown JM, Giaccia AJ, (1998) The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58: 1408-1416.
44. Netti PA, Hamberg LM, Babich JW, Kierstead D, Graham W, et al. (1999) Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules. Proc Natl Acad Sci U S A 96: 3137-3142.
45. Bjørnaes I, Rofstad EK, (2001) Microvascular permeability to macromolecules in human melanoma xenografts assessed by contrast-enhanced MRI-intertumor and intratumor heterogeneity. Magn Reson Imaging 19: 723-730.
46. Rofstad EK, Halsør EF, (2000) Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Cancer Res 60: 4932-4938.
47. Rofstad EK, Mathiesen B, (2010) Metastasis in melanoma xenografts is associated with tumor microvascular density rather than extent of hypoxia. Neoplasia 12: 889-898.
48. Ferretti S, Allegrini PR, Becquet MM, McSheehy PM, (2009) Tumor interstitial fluid pressure as an early-response marker for anticancer therapeutics. Neoplasia 11: 874-881.